Incorporating pulse wave velocity (PWV) and endothelial function assessments into routine clinical practice can significantly enhance the early identification of men at high risk for cardiovascular events. PWV, a marker of arterial stiffness, and flow-mediated dilation (FMD), a measure of endothelial function, provide valuable insights into vascular health beyond traditional risk factors such as hypertension, hyperlipidemia, and diabetes. Data from meta-analyses and clinical studies show strong associations between increased PWV, impaired endothelial function, and higher cardiovascular event rates. Implementing these assessments in routine screenings, particularly for men aged 40 and above or those with significant risk factors, can improve risk stratification and guide preventive strategies. Training healthcare providers, equipping clinics with appropriate devices, and educating patients about these tests’ importance are crucial steps for successful integration. By combining PWV and endothelial function testing with traditional risk factor assessments, clinicians can offer a more comprehensive evaluation of cardiovascular risk, leading to targeted interventions and improved long-term outcomes.